François Dauphin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
François Dauphin has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Edith Hamel
Laboratory of Cerebrovascular Research, Montreal Neurological Institute, McGill University, Montréal, Canada
2 shared publications - Valentine Bouet
University of Caen Normandy (UNICAEN), Institut National de la Santé et de la Recherche Médicale (INSERM), Mobilités : Vieillissement, Pathologie, Santé (COMETE), CYCERON, Centre Hospitalier Universitaire (CHU) Caen, Normandie Université, France
2 shared publications - Aurélie Malzert-Fréon
Université Caen Normandie, Normandie Univ, CERMN UR4258, F-14000 Caen, France
1 shared publication - Christophe Rochais
Université de Caen Normandie, Normandie Univ., CERMN, 14000, Caen, France
1 shared publication - Cédric Lecoutey
Normandie Univ, UNICAEN, CERMN, 14000 Caen, France
1 shared publication Céline Ballandonne
1 shared publication
Latest Publications
- 1 April 2017
- Published by Elsevier in Pharmacological Research
- Vol. 118, 111-118
Time-dependent impact of glutamatergic modulators on the promnesiant effect of 5-HT 6 R blockade on mice recognition memory
- 1 April 2017
- Published by Elsevier in Pharmacological Research
- Vol. 118, 111-118
Time-dependent impact of glutamatergic modulators on the promnesiant effect of 5-HT 6 R blockade on mice recognition memory
- 1 August 1994
- Published by Wiley in Journal of Neurochemistry
- Vol. 63 (2) , 544-551
Cholinergic Dilatation and Constriction of Feline Cerebral Blood Vessels Are Mediated by Stimulation of Phosphoinositide Metabolism via Two Different Muscarinic Receptor Subtypes
The muscarinic receptors involved in phosphoinositide (PI) hydrolysis have been pharmacologically characterized in cat cerebral blood vessels. Carbachol elicited a concentration‐dependent increase in inositol phosphate accumulation [inositol monophosphate, bisphosphate, trisphosphate (IP3) and tetrakisphosphate] in both major cerebral arteries and small pial vessels, which reached 140–280% of baseline at 10−3M carbachol (referred to as maximal effect). However, the inositol phosphate accumulation response was found to be biphasic with a submaximal effect (30–50% of the maximal stimulation) obtained at low carbachol concentrations ( pirenzepine (8.28) > 6‐chloro‐5,10‐dihydro‐5‐[(1‐methyl‐4‐piperidinyl)acetyl]‐11H‐dibenzo[b,e][1,4]diazepine‐11‐one (UH‐AH 371; 7.87) > 11‐[[2‐[(diethylamino)methyl]‐1‐piperidinyl]acetyl]‐5,‐11‐dihydro‐6H‐pyridol[2,3‐b][1,4]benzodiazepine‐6‐one (AF‐DX 116; 6.62), a pharmacological profile compatible with an M1 receptor subtype. In contrast, the submaximal stimulation of the PI metabolism elicited by 10−7M carbachol in major arteries was blocked by the same antagonists with the following order of potency (in ‐log IC50): 4‐DAMP (8.38) > pirenzepine (7.25) > UH‐AH 371 (6.25) > AF‐DX 116 (5.72), which was reminiscent of an M3 pharmacological profile. These findings indicate that stimulation of cerebrovascular muscarinic receptors is accompanied by PI hydrolysis via two distinct receptors, most probably the M1 and M3 subtypes that have been associated with constriction and dilatation, respectively, of cat cerebral arteries. Furthermore, these results provide strong evidence for an endothelial localization of the M3 dilatatory receptors within the vessel wall.
- 1 August 1994
- Published by Wiley in Journal of Neurochemistry
- Vol. 63 (2) , 544-551
Cholinergic Dilatation and Constriction of Feline Cerebral Blood Vessels Are Mediated by Stimulation of Phosphoinositide Metabolism via Two Different Muscarinic Receptor Subtypes
The muscarinic receptors involved in phosphoinositide (PI) hydrolysis have been pharmacologically characterized in cat cerebral blood vessels. Carbachol elicited a concentration‐dependent increase in inositol phosphate accumulation [inositol monophosphate, bisphosphate, trisphosphate (IP3) and tetrakisphosphate] in both major cerebral arteries and small pial vessels, which reached 140–280% of baseline at 10−3M carbachol (referred to as maximal effect). However, the inositol phosphate accumulation response was found to be biphasic with a submaximal effect (30–50% of the maximal stimulation) obtained at low carbachol concentrations ( pirenzepine (8.28) > 6‐chloro‐5,10‐dihydro‐5‐[(1‐methyl‐4‐piperidinyl)acetyl]‐11H‐dibenzo[b,e][1,4]diazepine‐11‐one (UH‐AH 371; 7.87) > 11‐[[2‐[(diethylamino)methyl]‐1‐piperidinyl]acetyl]‐5,‐11‐dihydro‐6H‐pyridol[2,3‐b][1,4]benzodiazepine‐6‐one (AF‐DX 116; 6.62), a pharmacological profile compatible with an M1 receptor subtype. In contrast, the submaximal stimulation of the PI metabolism elicited by 10−7M carbachol in major arteries was blocked by the same antagonists with the following order of potency (in ‐log IC50): 4‐DAMP (8.38) > pirenzepine (7.25) > UH‐AH 371 (6.25) > AF‐DX 116 (5.72), which was reminiscent of an M3 pharmacological profile. These findings indicate that stimulation of cerebrovascular muscarinic receptors is accompanied by PI hydrolysis via two distinct receptors, most probably the M1 and M3 subtypes that have been associated with constriction and dilatation, respectively, of cat cerebral arteries. Furthermore, these results provide strong evidence for an endothelial localization of the M3 dilatatory receptors within the vessel wall.
- 1 August 1991
- Published by Elsevier in European Journal of Pharmacology: Molecular Pharmacology
- Vol. 207 (4) , 319-327
Vasocontractile muscarinic M1 receptors in cat cerebral arteries: pharmacological identification and detection of mRNA
- 1 August 1991
- Published by Elsevier in European Journal of Pharmacology: Molecular Pharmacology
- Vol. 207 (4) , 319-327
Vasocontractile muscarinic M1 receptors in cat cerebral arteries: pharmacological identification and detection of mRNA